← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Rifampicin currently has availability issues reported in 4 European registers: Austria, Germany, Italy, Sweden.
Shortage ATC J04AB02 · also listed as: RIFAMPICIN · Rifampicin-Natrium · rifampicine · RIFAMPICINA · data refreshed 5 September 2026
As of 5 September 2026, 4 of the 9 tracked registers list current availability issues for Rifampicin, covering 9 affected product presentations. The longest-running open report was filed in Italy on 2021-08-05 and has now been open for about 61 months. Where agencies state a cause, unexpectedly high demand lead with 2 of the 3 stated-cause reports, followed by manufacturing problems with 1. The furthest expected-resolution date currently on file is 2026-12-31; the earliest is 2026-09-14. Notably, 2 reports have already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Momentum is current, not historical: 2 of the open reports were filed within the last 90 days. The issue spread across registers over time rather than at once: Italy reported first (2021-08-05), with Germany following roughly 60 months later — a pattern typical of supply problems cascading between national markets. Registers in Germany, Italy, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Rifampicin is coded J04AB02 — a medicine acting on anti-infectives for systemic use — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇦🇹 Austria | Limited availability Eremfat 450 mg - Filmtabletten + 1 more productsEremfat 600 mg - Filmtabletten | 2025-12-15 | — | — | register ↗ |
| 🇩🇪 Germany | Shortage Eremfat i.v. 300mg + 1 more productsEremfat i.v. 600mg | 2026-08-26 | 2026-09-14 | Erhöhte Nachfrage Alternatives: Eremfat i.v. 300mg - Einreichungsnummer: 2106370 | register ↗ |
| 🇫🇷 France | Resolved Rifadine 300 mg, gélule (boites de 30 et de 8 gélules) | — | 2026-07-20 | Infectiologie | register ↗ |
| 🇮🇹 Italy | Shortage RIFADIN | 2021-08-05 | — | Problemi produttivi Alternatives: AIFA: import of a foreign equivalent can be authorised. | register ↗ |
| 🇸🇪 Sweden | Shortage Rifampicin Ebb 300 mg Kapsel, hård + 3 more productsRifampicin Orifarm 300 mg Kapsel, hård Rimactan 150 mg Kapsel, hård Rimactan 300 mg Kapsel, hård | 2025-11-19 | 2026-12-31 | — Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Rifampicin in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇩🇪 DE | Eremfat i.v. 300mg | Shortage | 2026-08-26 | 2026-09-14 | Erhöhte Nachfrage |
| 🇩🇪 DE | Eremfat i.v. 600mg | Shortage | 2026-08-26 | 2026-09-14 | Erhöhte Nachfrage |
| 🇸🇪 SE | Rimactan 150 mg Kapsel, hård | Shortage | 2026-03-16 | 2026-12-20 | |
| 🇦🇹 AT | Eremfat 450 mg - Filmtabletten | Limited availability | 2025-12-15 | — | |
| 🇦🇹 AT | Eremfat 600 mg - Filmtabletten | Limited availability | 2025-12-15 | — | |
| 🇸🇪 SE | Rifampicin Ebb 300 mg Kapsel, hård | Shortage | 2025-11-26 | 2026-12-31 | |
| 🇸🇪 SE | Rifampicin Orifarm 300 mg Kapsel, hård | Shortage | 2025-11-25 | 2026-08-07 | |
| 🇸🇪 SE | Rimactan 300 mg Kapsel, hård | Shortage | 2025-11-19 | 2026-08-01 | |
| 🇮🇹 IT | RIFADIN | Shortage | 2021-08-05 | — | Problemi produttivi |
| 🇫🇷 FR | Rifadine 300 mg, gélule (boites de 30 et de 8 gélules) | Resolved | — | 2026-07-20 | Infectiologie |
Yes. As of 5 September 2026, availability issues are reported in: Austria, Germany, Italy, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-09-14 to 2026-12-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
7 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Rifampicin: BASG (Austria), BfArM (Germany), ANSM (France), AIFA (Italy), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Rifampicin — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/rifampicin/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Rifampicin availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/rifampicin/">Rifampicin shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>